Ebola Vaccine Canada - The stakes are high but the need and demand are skyrocketing as well. Hence, Canadian researchers are already paying volunteers to test their recently completed experimental Ebola vaccine.
According to CTVNews, the first doses of the experimental drug have already been administered to the first batch of volunteers who are willing to be test subjects in the Halifax experiment in exchange for cash.
The Ebola Vaccine in Canada is currently dubbed PSC1001, and as per the statements of the first volunteers, the drug is not at all that different from a flu shot.
"Right after, I felt totally fine. Yesterday evening, I felt a little feverish but it was nothing too serious. And today, I feel fine again," said 22-year-old volunteer Emily Sollows.
"For me, it was just about being part of such a potentially historical and groundbreaking study," she added. "And also, I'm a student so the money doesn't hurt either."
Researchers will be monitoring the volunteers in the next couple of days, in hopes of finding a positive infection-fighting response that is tolerable in the human body.
They will also be looking into the possible side effects of the Ebola Vaccine in Canada, and these side effects are expected to be pretty similar to the ones people who had flu vaccines experience i.e. mild fever and soreness at the site of administration.
Monitoring entails that each participant's vital signs will be monitored, as well as the possible effects the Ebola vaccine has in other blood components.
Urine and saliva samples will be collected from time to time and be sent to the National Microbiology Laboratory in Winnipeg, where the Ebola vaccine was developed in Canada.
As of late, the research team has only screened 60 volunteers from age 18 to 65. Each one final volunteer is to receive $1,100 provided that they follow to the guidelines of the research.
Initially, over 150 adults have offered the team to volunteer in the Canadian trial, but only 40 participants will be accepted by the researchers, according to CBC.
"There's been an extraordinary amount of interest in the study," said Dr. Scott Halperin, the study's principal investigator.
The Ebola Virus in Canada is reportedly made out of virus collected from cattle, pigs and horses.
The virus in the study has been altered by placing an Ebola virus gene among its genetic makeup. Researchers are hoping that this will be enough to trigger the human body to make antibodies against the Ebola virus protein found in the vaccine.
"You certainly can't get Ebola from it. Hopefully, what you do is get protection against Ebola," Halperin said.
The results of the experiment on the Ebola vaccine from Canada are expected to be out first thing in 2015,
This article is copyrighted by Travelers Today, the travel news leader
